PatientsVille.com Logo

PatientsVille

Celestene Side Effects

Common Celestene Side Effects


The most commonly reported Celestene side effects (click to view or check a box to report):

Hypoxia (4)
Oedema Peripheral (3)
Circulatory Collapse (3)
Pruritus (3)
Acute Pulmonary Oedema (3)
Agitation (3)
Foetal Exposure During Pregnancy (2)
Erythema (2)
Chest Pain (2)
Hepatocellular Injury (2)
Burning Sensation (2)
Dyspnoea (2)
Pneumococcal Infection (2)
Motor Dysfunction (2)
Lung Disorder (2)
No Therapeutic Response (2)
Osteonecrosis (2)
Stevens-johnson Syndrome (2)
Multiple Pregnancy (1)
Myocarditis (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Celestene Side Effects Reported to FDA

The following Celestene reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Celestene on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Septic Shock, Cellulitis
This is a report of a 57-year-old male patient (weight: NA) from FR, suffering from the following symptoms/conditions: tonsillitis, who was treated with Celestene (dosage: Unk, start time: Jan 11, 2012), combined with:
  • Rocephin (Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Septic Shock
  • Cellulitis
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Celestene treatment in male patients, resulting in septic shock side effect. The patient was hospitalized.

Stevens-johnson Syndrome
This report suggests a potential Celestene Stevens-johnson Syndrome side effect(s) that can have serious consequences. A 77-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Celestene (dosage: 1 Df, Qd) starting Nov 23, 2013. Soon after starting Celestene the patient began experiencing various side effects, including:
  • Stevens-johnson Syndrome
Drugs used concurrently:
  • Rocephin (Unk)
  • Oroken (Unk)
  • Surbronc (Unk)
  • Chondrosulf (Unk)
  • Acetaminophen (Unk)
  • Bronchokod (Unk)
  • Vibramycin (doxycycline) (Unk)
  • Triflucan (Unk)
The patient was hospitalized. Although Celestene demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as stevens-johnson syndrome, may still occur.

Diarrhoea, Agitation, Ventricular Extrasystoles
This Diarrhoea, Agitation, Ventricular Extrasystoles problem was reported by a health professional from FR. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: rhinitis,cough. On Oct 07, 2013 this consumer started treatment with Celestene (dosage: 200 Gtt, Bid). The following drugs were being taken at the same time: NA. When commencing Celestene, the patient experienced the following unwanted symptoms/side effects:
  • Diarrhoea
  • Agitation
  • Ventricular Extrasystoles
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as diarrhoea, may become evident only after a product is in use by the general population.

No Adverse Event
This is a report of a 2.-year-old male patient (weight: NA) from FR. The patient developed the following symptoms/conditions: NA and was treated with Celestene (dosage: Unk) starting Oct 08, 2013. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • No Adverse Event
The patient was hospitalized. This opens a possibility that Celestene treatment could cause the above reactions, including no adverse event, and some male subjects may be more susceptible.


Acute Pulmonary Oedema
A 31-year-old female patient (weight: NA) from FR with the following symptoms/conditions: NA started Celestene 4mg/1ml treatment (dosage: 12 Mg, Qd) on Oct 18, 2013. Soon after starting Celestene 4mg/1ml treatment, the subject experienced various side effects, including:
  • Acute Pulmonary Oedema
Concurrently used drugs:
  • Adalate (40 Mg, Qd)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Celestene 4mg/1ml.

Toxic Skin Eruption
A 24-year-old female patient from FR (weight: NA) experienced symptoms, such as: threatened labour and was treated with Celestene 4mg/1ml(dosage: Unk). The treatment was initiated on Jun 26, 2013. After that a consumer reported the following side effect(s):
  • Toxic Skin Eruption
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Celestene 4mg/1ml efficacy:
  • Adalate (Unk)
  • Tardyferon (Unk)
  • Mag 2 (Unk)
The patient was hospitalized.

Hepatitis
In this report, Celestene 8mg/2ml was administered for the following condition: NA.A 28-year-old female consumer from FR (weight: NA) started Celestene 8mg/2ml treatment (dosage: 12 Mg, Qd) on Apr 12, 2013.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Hepatitis
A possible interaction with other drugs could have contributed to this reaction:
  • Aldomet (methyldopa) (500 Mg, Bid)
  • Aldomet (methyldopa) (750 Mg, Bid)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Celestene 8mg/2ml treatment could be related to the listed above side effect(s).

Hepatocellular Injury, Cholestasis
This is a report of the following Celestene side effect(s):
  • Hepatocellular Injury
  • Cholestasis
A 84-year-old female patient from FR (weight: NA) presented with the following condition: NA and received a treatment with Celestene (dosage: Unk) starting: Mar 05, 2013.The following concurrently used drugs could have generated interactions:
  • Acetaminophen (2 G, Unk)
  • Acetaminophen (3 G, Once)
  • Celebrex (200 Mg, Bid)
  • Omeprazole (Unk)
  • Raniplex (Unk)
  • Augmentin (Unk)
  • Sevorane (Unk)
  • Sufentanil (Unk)
The patient was hospitalized.This report suggests that a Celestene treatment could be associated with the listed above side effect(s).

Erythema, Pyrexia, Urticaria, Arthralgia, Oedema Peripheral, Localised Oedema
This Celestene report was submitted by a 2.-year-old male consumer from FR (weight: NA). The patient was diagnosed with: otitis media and Celestene was administered (dosage: Unk) starting: Jan 16, 2013. The consumer developed a set of symptoms:
  • Erythema
  • Pyrexia
  • Urticaria
  • Arthralgia
  • Oedema Peripheral
  • Localised Oedema
Other drugs used simultaneously:
  • Augmentin (Unk)
The patient was hospitalized.Those unexpected symptoms could be linked to a Celestene treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Hepatitis Cholestatic, Granulomatous Liver Disease, Pruritus, Jaundice
This is a report of a possible correlation between Celestene use and the following symptoms/side effect(s):
  • Hepatitis Cholestatic
  • Granulomatous Liver Disease
  • Pruritus
  • Jaundice
which could contribute to an assessment of Celestene risk profile.A 57-year-old male consumer from FR (weight: NA) was suffering from NA and was treated with Celestene (dosage: Unk) starting Jan 16, 2013.Other concurrent medications:
  • Augmentin (Unk)
  • Augmentin (Unk)
  • Flagyl (Unk)
  • Codeine (Unk)
The patient was hospitalized.

Pancreatitis Acute, Disseminated Intravascular Coagulation, Hepatocellular Injury
A 4.-year-old female patient from FR (weight: NA) presented with the following symptoms: ear infection and after a treatment with Celestene (dosage: 200 Gtt, Qd) experienced the following side effect(s):
  • Pancreatitis Acute
  • Disseminated Intravascular Coagulation
  • Hepatocellular Injury
The treatment was started on Feb 12, 2013. Celestene was used in combination with the following drugs:
  • Fluimucil (200 Mg, Unk)
  • Solacy (1 Df, Unk)
The patient was hospitalized.This report could alert potential Celestene consumers.

Pancreatitis
In this report, a 62-year-old female patient from FR (weight: NA) was affected by a possible Celestene side effect.The patient was diagnosed with NA. After a treatment with Celestene (dosage: Unk, start date: Nov 09, 2012), the patient experienced the following side effect(s):
  • Pancreatitis
The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Celestene treatment.

Osteonecrosis
This is a report of a 37-year-old male patient from FR (weight: NA), who used Celestene (dosage: 2 Mg, Unk) for a treatment of NA. After starting a treatment on 201010, the patient experienced the following side effect(s):
  • Osteonecrosis
The following drugs could possibly have interacted with the Celestene treatment
  • Solupred (Unk)
  • Targretin (525 Mg, Qd)
  • Roferon-a (Unk Unk, Tiw)
  • Diprolene (Unk)
  • Betneval (Unk)
  • Desonide (Unk)
  • Diprosone (Unk)
  • Desonide (Unk)
The patient was hospitalized.Taken together, these observations suggest that a Celestene treatment could be related to side effect(s), such as Osteonecrosis.

Accidental Overdose
This accidental overdose side effect was reported by a health professional from FR. A .7-year-old male patient (weight:NA) experienced the following symptoms/conditions: bronchiolitis. The patient was prescribed Celestene (dosage: 90 Gtt, Tid), which was started on Dec 17, 2012. Concurrently used drugs:
  • Ventoline (albuterol) (1 Df, Tid)
  • Becotide (1 Df, Tid)
When starting to take Celestene the consumer reported the following symptoms:
  • Accidental Overdose
These side effects may potentially be related to Celestene.

Agitation, Incorrect Dose Administered
This is a Celestene side effect report of a female patient (weight:NA) from FR, suffering from the following symptoms/conditions: nasopharyngitis, who was treated with Celestene (dosage:160 Gtt, Bid, start time: Oct 06, 2012), combined with: NA., and developed a serious reaction and a agitation side effect. The patient presented with:
  • Agitation
  • Incorrect Dose Administered
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Celestene treatment in female patients suffering from nasopharyngitis, resulting in agitation.

Tendon Injury, Injury Associated With Device
This report suggests a potential Celestene 4mg/1ml tendon injury side effect(s) that can have serious consequences. A 81-year-old female patient from FR (weight:NA) was diagnosed with the following health condition(s): NA and used Celestene 4mg/1ml (dosage: NA) starting NS. Soon after starting Celestene 4mg/1ml the patient began experiencing various side effects, including:
  • Tendon Injury
  • Injury Associated With Device
Drugs used concurrently:
  • Kardegic
The patient was hospitalized. Although Celestene 4mg/1ml demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as tendon injury, may still occur.

Paraesthesia, Burning Sensation, Ocular Hyperaemia
This paraesthesia problem was reported by a health professional from FR. A 2-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Sep 23, 2012 a consumer started treatment with Celestene (dosage: 3 Gtt, Once). The following drugs/medications were being taken at the same time: NA. When commencing Celestene, the patient experienced the following unwanted symptoms /side effects:
  • Paraesthesia
  • Burning Sensation
  • Ocular Hyperaemia
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as paraesthesia, may become evident only after a product is in use by the general population.

Foetal Growth Restriction, Cerebral Haemorrhage, Foetal Exposure During Pregnancy
This is a Celestene 4mg/1ml side effect report of a 0-year-old female patient (weight: NA) from FR. The patient developed the following symptoms/conditions: NA and was treated with Celestene 4mg/1ml (dosage: Unk) starting Mar 10, 2012. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Foetal Growth Restriction
  • Cerebral Haemorrhage
  • Foetal Exposure During Pregnancy
The patient was hospitalized. This opens a possibility that Celestene 4mg/1ml could cause foetal growth restriction and that some female patients may be more susceptible.

Confusional State, Hyponatraemia
A 75-year-old male patient (weight: NA) from FR with the following symptoms: arthritis started Celestene treatment (dosage: 2 Mg, Bid) on Aug 16, 2012. Soon after starting Celestene treatment, the consumer experienced several side effects, including:
  • Confusional State
  • Hyponatraemia
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Celestene side effects, such as confusional state.

Sickle Cell Anaemia With Crisis
This sickle cell anaemia with crisis side effect was reported by a health professional from FR. A 41-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Celestene (dosage: Unk), which was started on 200903. Concurrently used drugs: NA..When starting to take Celestene the consumer reported symptoms, such as:
  • Sickle Cell Anaemia With Crisis
These side effects may potentially be related to Celestene.

Hypertrophic Cardiomyopathy, Foetal Exposure During Pregnancy
This is a report of a female patient (weight: NA) from TN, suffering from the following symptoms/conditions: NA, who was treated with Celestene Chronodose (dosage: 12 Mg, Qd, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Hypertrophic Cardiomyopathy
  • Foetal Exposure During Pregnancy
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Celestene Chronodose treatment in female patients, resulting in hypertrophic cardiomyopathy side effect. The patient was hospitalized.

Anaphylactic Reaction
This report suggests a potential Celestene (betamiethasone) (betamethasone /00008501/) Anaphylactic Reaction side effect(s) that can have serious consequences. A 33-year-old female patient (weight: NA) from FRANCE was diagnosed with the following symptoms/conditions: rhinitis,pharyngitis,ear infection and used Celestene (betamiethasone) (betamethasone /00008501/) (dosage: 4 Mg;oncce;po) starting Sep 02, 2010. Soon after starting Celestene (betamiethasone) (betamethasone /00008501/) the patient began experiencing various side effects, including:
  • Anaphylactic Reaction
Drugs used concurrently: NA.The patient was hospitalized. Although Celestene (betamiethasone) (betamethasone /00008501/) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as anaphylactic reaction, may still occur.

Acute Pulmonary Oedema, Acute Respiratory Failure, Chest Pain, Haemoptysis, Orthopnoea, Tachycardia
This Acute Pulmonary Oedema, Acute Respiratory Failure, Chest Pain, Haemoptysis, Orthopnoea, Tachycardia problem was reported by a physician from FRANCE. A 26-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jul 14, 2009 this consumer started treatment with Celestene (betamethasone Sodium Phosphate) (betamethasone Sodium Phosp (dosage: NA). The following drugs were being taken at the same time:
  • Nifedipine (20 Mg; Once;)
  • Tractocile /01459601/
When commencing Celestene (betamethasone Sodium Phosphate) (betamethasone Sodium Phosp, the patient experienced the following unwanted symptoms/side effects:
  • Acute Pulmonary Oedema
  • Acute Respiratory Failure
  • Chest Pain
  • Haemoptysis
  • Orthopnoea
  • Tachycardia
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as acute pulmonary oedema, may become evident only after a product is in use by the general population.

Pneumococcal Infection
This is a report of a 1-year-old female patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: cough,pyrexia and was treated with Celestene (betamethasone) (betamethasone) (dosage: 120 Gtt; Qd; Po) starting May 29, 2009. Concurrently used drugs:
  • Advil (1 Df; Prn; Po)
  • Nureflex (ibuprofen) (1 Df; Prn; Po)
  • Helicidine (helicidine) (5 Ml; Tid; Po)
  • Toplexil (aplexil) (5 Ml; Tid; Po)
Soon after that, the consumer experienced the following side effects:
  • Pneumococcal Infection
The patient was hospitalized. This opens a possibility that Celestene (betamethasone) (betamethasone) treatment could cause the above reactions, including pneumococcal infection, and some female subjects may be more susceptible.

Cardiac Arrest, Dyspnoea, Hypoxia, Myocarditis, Parvovirus Infection, Respiratory Tract Infection Viral, Viral Myocarditis, Vomiting
A 1-year-old female patient (weight: NA) from FRANCE with the following symptoms/conditions: dyspnoea,vaccinia virus infection started Celestene (betamethasone) (betamethasone) treatment (dosage: 165 Gtt; Once; Po) on Apr 29, 2009. Soon after starting Celestene (betamethasone) (betamethasone) treatment, the subject experienced various side effects, including:
  • Cardiac Arrest
  • Dyspnoea
  • Hypoxia
  • Myocarditis
  • Parvovirus Infection
  • Respiratory Tract Infection Viral
  • Viral Myocarditis
  • Vomiting
Concurrently used drugs:
  • Prevenar (pneumococcal Conjugate Vaccine) (Intramuscular)
  • Prevenar (pneumococcal Conjugate Vaccine) (Intramuscular)
  • Prevenar (pneumococcal Conjugate Vaccine) (Intramuscular)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Celestene (betamethasone) (betamethasone).

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Celestene Side Effects

    Did You Have a Celestene Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Celestene for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Celestene Safety Alerts, Active Ingredients, Usage Information

    More About Celestene

    Side Effects reported to FDA: 48

    Celestene safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 10

    Latest Celestene clinical trials